Assessment Of Vascular Health After Niacin Therapy (AVANT)

NCT02003638 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Carotid Artery Disease
Peripheral Artery Disease

Interventions

DRUG: Niacin
DRUG: Placebo

Sponsor

University of Pennsylvania